Bill

Bill > HB0111


TN HB0111

AN ACT to amend Tennessee Code Annotated, Section 68-5-602, relative to maternal health screening.


summary

Introduced
01/13/2025
In Committee
02/25/2025
Crossed Over
Passed
03/28/2025
Dead
Signed/Enacted/Adopted
03/28/2025

Introduced Session

114th General Assembly

Bill Summary

As enacted, adds as a disease for which a laboratory must test during a standard serological test of a pregnant woman hepatitis C antibody (anti-HCV) with automatic reflex to HCV RNA if anti-HCV is reactive, and makes certain other changes to the process of conducting required pregnancy serological tests. - Amends TCA Section 68-5-602.

AI Summary

This bill amends Tennessee's maternal health screening requirements to expand blood testing protocols for pregnant women. Specifically, the legislation mandates that during the first prenatal examination (or within 10 days after), healthcare providers must now test blood samples for an additional disease: hepatitis C antibody (anti-HCV), with an automatic follow-up RNA test if the initial antibody test is reactive. The bill maintains existing requirements for testing syphilis, rubella immunity, and hepatitis B surface antigen, and continues to require additional syphilis testing between the 28th and 32nd weeks of pregnancy and again at delivery. Healthcare providers who are not legally permitted to draw blood must ensure that a qualified health professional takes the required blood samples. All positive tests for syphilis, hepatitis B, and hepatitis C must still be reported to the local health department. The law is set to take effect on July 1, 2025, with the stated purpose of promoting public welfare by enhancing early detection of infectious diseases during pregnancy.

Committee Categories

Health and Social Services

Sponsors (9)

Last Action

Comp. became Pub. Ch. 46 (on 03/28/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...